TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis

BACKGROUND: The acquisition of drug resistance has been considered as a main obstacle for cancer chemotherapy. Tumor protein 53 target gene 1 (TP53TG1), a p53-induced lncRNA, plays a vital role in the progression of human cancers. However, little is known about the detailed function and molecular me...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Huijuan, Liu, Yihe, Liang, Pan, Wang, Bo, Tan, Hongna, Zhang, Yonggao, Gao, Xianzheng, Gao, Jianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863826/
https://www.ncbi.nlm.nih.gov/pubmed/29588850
http://dx.doi.org/10.1186/s13578-018-0221-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863826/
https://www.ncbi.nlm.nih.gov/pubmed/29588850
http://dx.doi.org/10.1186/s13578-018-0221-7

Ejemplares similares